NYMX

Nymox Pharmaceutical Corp
NYMX

Overview Fund Activity
Delisted

NYMX was delisted on the 6th of July, 2023.

Back to rankings

47 hedge funds and large institutions have $6.32M invested in Nymox Pharmaceutical Corp in 2020 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 10 increasing their positions, 9 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
47
Holders Change
+2
Holders Change %
+4.44%
% of All Funds
1.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
10
Reduced
9
Closed
8
Calls
$99K
Puts
$113K
Net Calls
-$14K
Net Calls Change
-$1K

Top Buyers

1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$536K
2
Goldman Sachs
Goldman Sachs
New York
+$280K
3
Renaissance Technologies
Renaissance Technologies
New York
+$162K
4
Millennium Management
Millennium Management
New York
+$104K
5
FCFC
First Citizens Financial Corp
Iowa
+$82K

Top Sellers

1
6CM
683 Capital Management
New York
-$189K
2
Bank of America
Bank of America
North Carolina
-$98.6K
3
ECM
ExodusPoint Capital Management
New York
-$96.8K
4
FDCDDQ
Federation des caisses Desjardins du Quebec
Quebec, Canada
-$81.9K
5
Citadel Advisors
Citadel Advisors
Florida
-$63K
Name Holding Trade Value Shares
Change 		Shares
Change %
AGM
51
Alpine Global Management
New York
– -$38K -17,196 Closed
TRCT
52
Tower Research Capital (TRC)
New York
– -$25K -11,515 Closed
LNC
53
Lincoln National Corp
Pennsylvania
– -$22K -10,000 Closed
SPIA
54
Steward Partners Investment Advisory
New York
– -$1K -600 Closed
VRM
55
Vectors Research Management
New York
– -$1K -500 Closed
1 2
3